FLGT Fulgent Genetics Inc
Price (delayed)
$16.98
Market cap
$523.48M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.41
Enterprise value
$468.75M
Fulgent Genetics' proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high
Highlights
The net income has soared by 75% YoY and by 74% from the previous quarter
FLGT's EPS has soared by 75% year-on-year and by 74% since the previous quarter
FLGT's quick ratio is down by 31% year-on-year but it is up by 23% since the previous quarter
Key stats
What are the main financial stats of FLGT
Market
Valuations
Earnings
Shares outstanding
30.83M
Market cap
$523.48M
Enterprise value
$468.75M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.46
Price to sales (P/S)
1.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.65
Revenue
$283.47M
Gross profit
$107.22M
Operating income
-$73.92M
Net income
-$42.71M
EBIT
-$51.01M
EBITDA
-$22.33M
Free cash flow
-$18.94M
Per share
Balance sheet
Liquidity
EPS
-$1.41
EPS diluted
-$1.41
Free cash flow per share
-$0.63
Book value per share
$37.05
Revenue per share
$9.38
TBVPS
$35.16
Total assets
$1.22B
Total liabilities
$90.81M
Debt
$412,000
Equity
$1.13B
Working capital
$280.67M
Debt to equity
0
Current ratio
4.85
Quick ratio
4.49
Net debt/EBITDA
2.45
Margins
Efficiency
Dividend
EBITDA margin
-7.9%
Gross margin
37.8%
Net margin
-15.1%
Operating margin
-26.1%
Return on assets
-3.5%
Return on equity
-3.8%
Return on invested capital
-5.4%
Return on capital employed
-4.4%
Return on sales
-18%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
FLGT stock price
How has the Fulgent Genetics stock price performed over time
Intraday
-2.86%
1 week
-5.14%
1 month
0.71%
1 year
-26.33%
YTD
-8.07%
QTD
-8.07%
Financial performance
How have Fulgent Genetics's revenue and profit performed over time
Revenue
$283.47M
Gross profit
$107.22M
Operating income
-$73.92M
Net income
-$42.71M
Gross margin
37.8%
Net margin
-15.1%
The net income has soared by 75% YoY and by 74% from the previous quarter
Fulgent Genetics's net margin has soared by 75% from the previous quarter and by 74% YoY
Fulgent Genetics's operating income has soared by 65% from the previous quarter and by 62% YoY
Fulgent Genetics's operating margin has soared by 65% from the previous quarter and by 61% YoY
Growth
What is Fulgent Genetics's growth rate over time
Valuation
What is Fulgent Genetics stock price valuation
P/E
N/A
P/B
0.46
P/S
1.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.65
FLGT's EPS has soared by 75% year-on-year and by 74% since the previous quarter
The price to book (P/B) is 73% lower than the 5-year quarterly average of 1.7 and 8% lower than the last 4 quarters average of 0.5
FLGT's P/S is 43% below its 5-year quarterly average of 3.2 and 18% below its last 4 quarters average of 2.2
Fulgent Genetics's revenue has increased by 2.1% QoQ
Efficiency
How efficient is Fulgent Genetics business performance
The company's return on assets has surged by 74% QoQ and by 72% YoY
The return on equity has surged by 74% since the previous quarter and by 72% year-on-year
FLGT's ROS has soared by 73% since the previous quarter and by 69% year-on-year
The company's return on invested capital has surged by 72% QoQ and by 70% YoY
Dividends
What is FLGT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for FLGT.
Financial health
How did Fulgent Genetics financials performed over time
FLGT's quick ratio is down by 31% year-on-year but it is up by 23% since the previous quarter
FLGT's current ratio is down by 30% year-on-year but it is up by 10% since the previous quarter
Fulgent Genetics's debt is 100% less than its equity
Fulgent Genetics's debt has plunged by 65% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.